BiomX acquires 10% of drone-testing firm MEA; gains option to buy rest

BiomX Inc.

BiomX pays $50K and issues 1.3M restricted shares for 10% of MEA; option to acquire remaining ~78.9% through June 30, 2028.
Option price: 2x 2027 net revenue or 4x 2027 EBITDA, at BiomX's election; payable in cash or stock.
Closing requires NYSE American approval, due diligence, and exclusive perpetual license to MEA drone-testing tech.
MEA's customers reportedly include Israel Aerospace Industries and Elbit Systems; subject to due diligence.
MEA assets carry Bank Hapoalim lien; option close requires cash-free, debt-free delivery of MEA companies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.